U.S. judge in Anthem merger trial sets trial for November 21, plans ruling by late January 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Credit Suisse Remains Sidelined on Humana (HUM) After Meeting with Management
August 16, 2016 11:00 AM EDTCredit Suisse reiterated a Neutral rating on Humana (NYSE: HUM), and raised the price target to $188.00 (from $175.00), after meeting with the company's CFO and VP/IR.
Analyst Scott Fidel commented, "We hosted HUM's CFO and VP/IR for investor meetings in NYC. Relative to AET deal, HUM believes it has... More
